Thymidine phosphorylase affects clinical outcome following surgery and mRNA expression levels of four key enzymes for 5‑fluorouracil metabolism in patients with stage I and II non‑small cell lung cancer

Himuro,Naoya; Niiya,Yumiko; Minakata,Takao; Oshima,Yutaka; Kataoka,Daisuke; Yamamoto,Shigeru; Suzuki,Takashi; Kadokura,Mitsutaka

doi:10.3892/mco.2018.1726

Thymidine phosphorylase affects clinical outcome following surgery and mRNA expression levels of four key enzymes for 5‑fluorouracil metabolism in patients with stage I and II non‑small cell lung cancer

Authors:
- Naoya Himuro
- Yumiko Niiya
- Takao Minakata
- Yutaka Oshima
- Daisuke Kataoka
- Shigeru Yamamoto
- Takashi Suzuki
- Mitsutaka Kadokura
View Affiliations

Affiliations: Division of Chest Surgery, Department of Surgery, Showa University School of Medicine, Tokyo 142‑8666, Japan
Published online on: September 25, 2018 https://doi.org/10.3892/mco.2018.1726
Pages: 640-646

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The expression levels of thymidine phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD), thymidylate synthase (TS) and orotate phosphoribosyltransferase (OPRT) may predict the clinical efficacy of 5‑fluorouracil‑based chemotherapy in patients with cancer. We herein investigated the differences in the mRNA levels of these enzymes in non‑small‑cell lung cancer (NSCLC) and evaluated their prognostic value for NSCLC treated by surgical resection. The intratumoral mRNA levels of TP, DPD, TS, and OPRT were quantified in 66 patients with pathological stage I and II NSCLC (adenocarcinoma or squamous cell carcinoma) following complete resection according to the Danenberg Tumor Profile method. The TP level was the only significant prognostic factor for disease‑specific survival (DSS) following complete resection; the mean TP mRNA level differed significantly between the high and low mRNA expression groups. The DSS at 5 years was significantly higher in the low TP mRNA compared with that in the high TP mRNA expression group (83.4 vs. 58.6%, respectively; P=0.005). A Cox proportional hazards model revealed that pathological stage, sex, and TP expression were independent prognostic factors for DSS in patients with stage I and II NSCLC following complete resection. Thus, TP level may be used to monitor treatment efficacy and predict the outcome of NSCLC patients.

View Figures

View References

1	Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery, . Masuda M, Kuwano H, Okumura M, Arai H, Endo S, Doki Y, Kobayashi J, Motomura N, et al: Thoracic and cardiovascular surgery in Japan during 2013: Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 63:670–701. 2015. View Article : Google Scholar : PubMed/NCBI
2	Sawabata N, Miyaoka E, Asamura H, Nakanishi Y, Eguchi K, Mori M, Nomori H, Fujii Y, Okumura M and Yokoi K; Japanese Joint Committee for Lung Cancer Registration, : Japanese lung cancer registry study of 11,663 surgical cases in 2004: Demographic and prognosis changes over decade. J Thorac Oncol. 6:1229–1235. 2011. View Article : Google Scholar : PubMed/NCBI
3	Brabender J, Park J, Metzger R, Schneider PM, Lord RV, Hölscher AH, Danenberg KD and Danenberg PV: Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer. Ann Surg. 235:440–443. 2002. View Article : Google Scholar : PubMed/NCBI
4	Grimminger P, Ling FC, Neiss S, Vallböhmer D, Lurje G, Schneider PM, Hölscher AH, Metzger R and Brabender J: The role of the homeobox genes BFT and CDX2 in the pathogenesis of non-small cell lung cancer. Anticancer Res. 29:1281–1286. 2009.PubMed/NCBI
5	Farrugia DC, Ford HE, Cunningham D, Danenberg KD, Danenberg PV, Brabender J, McVicar AD, Aherne GW, Hardcastle A, McCarthy K and Jackman AL: Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed. Clin Cancer Res. 9:792–801. 2003.PubMed/NCBI
6	Lenz HJ, Leichman CG, Danenberg KD, Danenberg PV, Groshen S, Cohen H, Laine L, Crookes P, Silberman H, Baranda J, et al: Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overall survival. J Clin Oncol. 14:176–182. 1996. View Article : Google Scholar : PubMed/NCBI
7	Miyoshi Y, Uemura H, Ishiguro H, Kitamura H, Nomura N, Danenberg PV and Kubota Y: Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer. Prostate Cancer Prostatic Dis. 8:260–265. 2005. View Article : Google Scholar : PubMed/NCBI
8	Uchida K, Danenberg PV, Danenberg KD and Grem JL: Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine. BMC Cancer. 8:3862008. View Article : Google Scholar : PubMed/NCBI
9	Wada H, Hitomi S and Teramatsu T: Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. J Clin Oncol. 14:1048–1054. 1996. View Article : Google Scholar : PubMed/NCBI
10	Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N, et al: A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 350:1713–1721. 2004. View Article : Google Scholar : PubMed/NCBI
11	Sobin LH, Gospodarowicz MK and Wittekind Ch: International Union Against Cancer (UICC) TNM Classification of Malignant Tumours. 7th. Oxford, UK: Wiley-Blackwell; 2009
12	Horikoshi T, Danenberg K, Volkenandt M, Stadlbauer T and Danenberg PV: Quantitative measurement of relative gene expression in human tumors. Methods Mol Biol. 15:177–188. 1993.PubMed/NCBI
13	Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, Johansson J, Skinner KA, Chandrasoma P, DeMeester SR, et al: Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, carcinoma sequence. Gastrointest Surg. 4:135–142. 2000. View Article : Google Scholar
14	Matsubara J, Nishina T, Yamada Y, Moriwaki T, Shimoda T, Kajiwara T, Nakajima TE, Kato K, Hamaguchi T, Shimada Y, et al: Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. Br J Cancer. 98:832–839. 2008. View Article : Google Scholar : PubMed/NCBI
15	Eguchi K, Oyama T, Tajima A, Abiko T, Sawafuji M, Horio H, Hashizume T, Matsutani N, Kato R, Nakayama M, et al: Intratumoral gene expression of 5-fluorouracil pharmacokinetics-related enzymes in stage I and II non-small cell lung cancer patients treated with uracil-tegafur after surgery: A prospective multi-institutional study in Japan. Lung Cancer. 87:53–58. 2015. View Article : Google Scholar : PubMed/NCBI
16	Mochinaga K, Tsuchiya T, Nagasaki T, Arai J, Tominaga T, Yamasaki N, Matsumoto K, Miyazaki T, Nanashima A, Hayashi T, et al: High expression of dihydropyrimidine dehydrogenase in lung adenocarcinoma is associated with mutations in epidermal growth factor receptor: Implications for the treatment of NSCLC using 5-fluorouracil. Clin Lung Cancer. 15:136–140.e4. 2014. View Article : Google Scholar : PubMed/NCBI
17	Tominaga T, Tsuchiya T, Mochinaga K, Arai J, Yamasaki N, Matsumoto K, Miyazaki T, Nagasaki T, Nanashima A, Tsukamoto K and Nagayasu T: Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer. BMC Cancer. 16:3542016. View Article : Google Scholar : PubMed/NCBI
18	Mizutani Y, Wada H, Fukushima M, Yoshida O, Nakanishi H, Li YN and Miki T: Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma. Cancer. 100:723–731. 2004. View Article : Google Scholar : PubMed/NCBI
19	Mackintosh JA, Marshall HM, Yang IA, Bowman RV and Fong KM: A retrospective study of volume doubling time in surgically resected non-small cell lung cancer. Respirology. 19:755–762. 2014. View Article : Google Scholar : PubMed/NCBI
20	Lee SW, Chen TJ, Lin LC, Li CF, Chen LT, Hsing CH, Hsu HP, Tsai CJ, Huang HY and Shiue YL: Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma. Exp Mol Pathol. 95:83–90. 2013. View Article : Google Scholar : PubMed/NCBI
21	Shintani Y, Ohta M, Hirabayashi H, Tanaka H, Iuchi K, Nakagawa K, Maeda H, Kido T, Miyoshi S and Matsuda H: Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer. Lung Cancer. 45:189–196. 2004. View Article : Google Scholar : PubMed/NCBI
22	Nakano J, Huang C, Liu D, Masuya D, Nakashima T, Yokomise H, Ueno M, Wada H and Fukushima M: Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT. Br J Cancer. 95:607–615. 2006. View Article : Google Scholar : PubMed/NCBI
23	Basaki Y, Chikahisa L, Aoyagi K, Miyadera K, Yonekura K, Hashimoto A, Okabe S, Wierzba K and Yamada Y: Gamma-hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor. Angiogenesis. 4:163–173. 2001. View Article : Google Scholar : PubMed/NCBI
24	Ishihama H, Chida M, Araki O, Karube Y, Seki N, Tamura M, Umezu H, Honma K, Masawa N and Miyoshi S: Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung. Jpn J Clin Oncol. 39:33–36. 2009. View Article : Google Scholar : PubMed/NCBI
25	Che J, Pan L, Yang X, Liu Z, Huang L, Wen C, Lin A and Liu H: Thymidine phosphorylase expression and prognosis in colorectal cancer treated with 5-fluorouracil-based chemotherapy: A meta-analysis. Mol Clin Oncol. 7:943–952. 2017.PubMed/NCBI
26	Elamin YY, Rafee S, Osman N, Byrne O KJ and Gately K: Thymidine phosphorylase in cancer; enemy or friend? Cancer Microenviron. 1:33–43. 2016. View Article : Google Scholar
27	Metzger R, Danenberg K, Leichman CG, Salonga D, Schwartz EL, Wadler S, Lenz HJ, Groshen S, Leichman L and Danenberg PV: High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil. Clin Cancer Res. 4:2371–2376. 1998.PubMed/NCBI
28	Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H and Tominaga T: Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer. 64:79–82. 1995. View Article : Google Scholar : PubMed/NCBI
29	Amaya H, Tanigawa N, Lu C, Matsumura M, Shimomatsuya T, Horiuchi T and Muraoka R: Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer. Cancer Lett. 119:227–235. 1997. View Article : Google Scholar : PubMed/NCBI
30	Maeda K, Kang SM, Ogawa M, Onoda N, Sawada T, Nakata B, Kato Y, Chung YS and Sowa M: Combined analysis of vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression in gastric carcinoma. Int J Cancer. 74:545–550. 1997. View Article : Google Scholar : PubMed/NCBI
31	Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter KC and Harris AL: Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer. 75:477–481. 1997. View Article : Google Scholar : PubMed/NCBI
32	Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI and Griffiths K: A prognostic index in primary breast cancer. Br J Cancer. 45:361–366. 1982. View Article : Google Scholar : PubMed/NCBI
33	Tsuji T, Sawai T, Yamashita H, Takeshita H, Nakagoe T, Shindou H, Fukuoka H, Yoshinaga M, Hidaka S, Yasutake T, et al: Platelet-derived endothelial cell growth factor expression is an independent prognostic factor in colorectal cancer patients after curative surgery. Eur J Surg Oncol. 30:296–302. 2004. View Article : Google Scholar : PubMed/NCBI
34	Tsunoda Y, Suzuki K, Tsunoda A, Takimoto M and Kusano M: Evaluation of 5-fluorouracil related genes in breast cancer to predict the effect of adjuvant therapy with oral fluorouracil derivatives. Oncol Rep. 23:771–777. 2010.PubMed/NCBI
35	Nishina T, Hyodo I, Miyaike J, Inaba T, Suzuki S and Shiratori Y: The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5′-deoxy-5-fluorouridine. Eur J Cancer. 40:1556–1571. 2004. View Article : Google Scholar
36	Ahlin C, Aaltonen K, Amini RM, Nevanlinna H, Fjällskog ML and Blomqvist C: Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values? Histopathology. 51:491–498. 2007. View Article : Google Scholar : PubMed/NCBI
37	Kojima H, Shijubo N and Abe S: Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma. Cancer. 94:1083–1093. 2002. View Article : Google Scholar : PubMed/NCBI